Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein.
To investigate whether resveratrol, a polyphenolic compound in red wine, affects the oxidation of human low density lipoprotein (LDL), LDL purified from normolipidemic subjects was subjected to Cu(2+)-induce and azo compound-initiated oxidative modification, with and without the addition of varying concentrations of resveratrol. Modification of LDL was assessed by the formation of thiobarbituric acid reactive substances (TBARS) and changes in the relative electrophoretic mobility (REM) of LDL on agarose gels. Resveratrol (50 microM) reduced TBARS and REM of LDL during Cu(2+)-induced oxidation by 70.5% and 42.3%, respectively (p < 0.01), and prolonged the lag phase associated with the oxidative modification of LDL by copper ion or azo compound. These in vitro results suggest that resveratrol may afford protection of LDL against oxidative damage resulting from exposure to various environmental challenges, possibly by acting as a free radical scavenger.
Department of Cardiology, Nanjing Medical University, China.
J G
JG
Zou
Y Z
YZ
Huang
Q
Q
Chen
E H
EH
Wei
T C
TC
Hsieh
J M
JM
Wu
D000578:Amidines / Q000737:chemistry; D001391:Azo Compounds; D003300:Copper; D004587:Electrophoresis, Agar Gel; D016166:Free Radical Scavengers / Q000494:pharmacology; D006801:Humans; D008077:Lipoproteins, LDL / Q000737:chemistry*; D008315:Malondialdehyde / Q000032:analysis; D010084:Oxidation-Reduction; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*; D017392:Thiobarbituric Acid Reactive Substances / Q000032:analysis; D013997:Time Factors
D000578:Amidines; D001391:Azo Compounds; D016166:Free Radical Scavengers; D008077:Lipoproteins, LDL; D013267:Stilbenes; D017392:Thiobarbituric Acid Reactive Substances; C099252:oxidized low density lipoprotein; D008315:Malondialdehyde; C046728:2,2'-azobis(2-amidinopropane); D003300:Copper; D000077185:Resveratrol